GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (NYSE:PRGO) » Definitions » Cyclically Adjusted PS Ratio

Perrigo Co (Perrigo Co) Cyclically Adjusted PS Ratio : 0.85 (As of Apr. 27, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Perrigo Co Cyclically Adjusted PS Ratio?

As of today (2024-04-27), Perrigo Co's current share price is $31.94. Perrigo Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $37.74. Perrigo Co's Cyclically Adjusted PS Ratio for today is 0.85.

The historical rank and industry rank for Perrigo Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

PRGO' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.7   Med: 2.1   Max: 7.64
Current: 0.83

During the past years, Perrigo Co's highest Cyclically Adjusted PS Ratio was 7.64. The lowest was 0.70. And the median was 2.10.

PRGO's Cyclically Adjusted PS Ratio is ranked better than
75.41% of 736 companies
in the Drug Manufacturers industry
Industry Median: 2.06 vs PRGO: 0.83

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Perrigo Co's adjusted revenue per share data for the three months ended in Dec. 2023 was $8.532. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $37.74 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Perrigo Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Perrigo Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Cyclically Adjusted PS Ratio Chart

Perrigo Co Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.53 1.33 1.10 0.91 0.85

Perrigo Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 0.94 0.89 0.83 0.85

Competitive Comparison of Perrigo Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perrigo Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Perrigo Co's Cyclically Adjusted PS Ratio falls into.



Perrigo Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Perrigo Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=31.94/37.74
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perrigo Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Perrigo Co's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=8.532/120.1096*120.1096
=8.532

Current CPI (Dec. 2023) = 120.1096.

Perrigo Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 7.477 100.573 8.929
201406 7.433 100.773 8.859
201409 7.080 100.474 8.464
201412 7.834 99.576 9.449
201503 7.451 99.975 8.952
201506 7.872 100.573 9.401
201509 9.154 100.274 10.965
201512 9.823 99.676 11.837
201603 9.659 99.676 11.639
201606 9.361 101.072 11.124
201609 8.804 100.274 10.546
201612 9.271 99.676 11.172
201703 8.315 100.374 9.950
201706 8.639 100.673 10.307
201709 8.689 100.474 10.387
201712 9.036 100.075 10.845
201803 8.607 100.573 10.279
201806 8.554 101.072 10.165
201809 8.247 101.371 9.772
201812 8.775 100.773 10.459
201903 8.623 101.670 10.187
201906 8.418 102.168 9.896
201909 8.707 102.268 10.226
201912 2.597 102.068 3.056
202003 7.890 102.367 9.257
202006 6.900 101.769 8.143
202009 7.289 101.072 8.662
202012 7.727 101.072 9.182
202103 7.504 102.367 8.805
202106 7.344 103.364 8.534
202109 7.793 104.859 8.926
202112 8.252 106.653 9.293
202203 8.019 109.245 8.817
202206 8.334 112.734 8.879
202209 8.174 113.431 8.655
202212 8.570 115.425 8.918
202303 8.760 117.618 8.946
202306 8.734 119.611 8.770
202309 8.209 120.708 8.168
202312 8.532 120.110 8.532

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Perrigo Co  (NYSE:PRGO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Perrigo Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Perrigo Co (Perrigo Co) Business Description

Traded in Other Exchanges
Address
The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Executives
Robert Willis officer: Acting CHRO C/O PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Alison Ives officer: EVP & Chief Scientific Officer C/O PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Eduardo Guarita Bezerra officer: EVP & Chief Financial Officer C/O FRESH DEL MONTE PRODUCE INC., PO BOX 149222, CORAL GABLES FL 33134
Patrick Lockwood-taylor director, officer: CEO C/O PERRIGO COMPANY PLC, 430 MONROE AVE NW, GRAND RAPIDS MI 49503
Julia M Brown director C/O ABLE BRANDS CO., 30 HUDSON YARDS, NEW YORK NY 10001
Triona Schmelter officer: EVP & President CSCA 2021 SPRING ROAD, SUITE 600, OAK BROOK IL 60523
Geoffrey M. Parker director 15 RIORDAN PLACE, MENLO PARK CA 94025
Svend Andersen director C/O PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Murray S Kessler director, officer: CEO 714 GREEN VALLEY ROAD, GREENSBORO NC 27408
Thomas Farrington officer: Senior VP and CIO 4012 W. CANTERBURY CT., NEQUON WI 53092
Dillard James E Iii officer: EVP, Chief Scientific Officer 6601 WEST BROAD STREET, RICHMOND VA 23230
Ronald Craig Janish officer: EVP, Global Op. & Supply Chain PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Grainne Quinn officer: EVP, Chief Medical Officer PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN MI 49010
Albert Manzone director C/O MERISANT, AVENUE JEAN-JACQUES ROUSSEAU 7, NEUCHATEL V8 CH-2000
Kyle Hanson officer: EVP & General Counsel